195 related articles for article (PubMed ID: 24029391)
1. Fractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy.
Matoba M; Tuji H; Shimode Y; Toyoda I; Kuginuki Y; Miwa K; Tonami H
AJNR Am J Neuroradiol; 2014 Feb; 35(2):379-85. PubMed ID: 24029391
[TBL] [Abstract][Full Text] [Related]
2. Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma.
Srinivasan A; Chenevert TL; Dwamena BA; Eisbruch A; Watcharotone K; Myles JD; Mukherji SK
J Comput Assist Tomogr; 2012; 36(1):131-7. PubMed ID: 22261783
[TBL] [Abstract][Full Text] [Related]
3. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: preliminary results from a prospective pilot study.
Ding Y; Hazle JD; Mohamed AS; Frank SJ; Hobbs BP; Colen RR; Gunn GB; Wang J; Kalpathy-Cramer J; Garden AS; Lai SY; Rosenthal DI; Fuller CD
NMR Biomed; 2015 Dec; 28(12):1645-54. PubMed ID: 26451969
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted imaging for head and neck squamous cell carcinoma: quantifying repeatability to understand early treatment-induced change.
Hoang JK; Choudhury KR; Chang J; Craciunescu OI; Yoo DS; Brizel DM
AJR Am J Roentgenol; 2014 Nov; 203(5):1104-8. PubMed ID: 25341151
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted Magnetic Resonance Imaging for Predicting Response to Chemoradiation Therapy for Head and Neck Squamous Cell Carcinoma: A Systematic Review.
Chung SR; Choi YJ; Suh CH; Lee JH; Baek JH
Korean J Radiol; 2019 Apr; 20(4):649-661. PubMed ID: 30887747
[TBL] [Abstract][Full Text] [Related]
6. Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response.
King AD; Chow KK; Yu KH; Mo FK; Yeung DK; Yuan J; Bhatia KS; Vlantis AC; Ahuja AT
Radiology; 2013 Feb; 266(2):531-8. PubMed ID: 23151830
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response.
King AD; Mo FK; Yu KH; Yeung DK; Zhou H; Bhatia KS; Tse GM; Vlantis AC; Wong JK; Ahuja AT
Eur Radiol; 2010 Sep; 20(9):2213-20. PubMed ID: 20309553
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of combined assessments of 4D volumetric perfusion CT, diffusion-weighted MRI and
Tsuchiya H; Matoba M; Nishino Y; Ota K; Doai M; Nagata H; Tuji H
Radiat Oncol; 2023 Feb; 18(1):24. PubMed ID: 36747228
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging.
Hwang I; Choi SH; Kim YJ; Kim KG; Lee AL; Yun TJ; Kim JH; Sohn CH
AJNR Am J Neuroradiol; 2013 Dec; 34(12):2343-8. PubMed ID: 23811978
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck.
Chawla S; Kim S; Dougherty L; Wang S; Loevner LA; Quon H; Poptani H
AJR Am J Roentgenol; 2013 Jan; 200(1):35-43. PubMed ID: 23255739
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067
[TBL] [Abstract][Full Text] [Related]
12. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
[TBL] [Abstract][Full Text] [Related]
14. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.
Paudyal R; Oh JH; Riaz N; Venigalla P; Li J; Hatzoglou V; Leeman J; Nunez DA; Lu Y; Deasy JO; Lee N; Shukla-Dave A
J Magn Reson Imaging; 2017 Apr; 45(4):1013-1023. PubMed ID: 27862553
[TBL] [Abstract][Full Text] [Related]
15. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
16. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy.
Hatakenaka M; Nakamura K; Yabuuchi H; Shioyama Y; Matsuo Y; Ohnishi K; Sunami S; Kamitani T; Setoguchi T; Yoshiura T; Nakashima T; Nishikawa K; Honda H
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):339-45. PubMed ID: 20832179
[TBL] [Abstract][Full Text] [Related]
18. CT Texture Analysis Potentially Predicts Local Failure in Head and Neck Squamous Cell Carcinoma Treated with Chemoradiotherapy.
Kuno H; Qureshi MM; Chapman MN; Li B; Andreu-Arasa VC; Onoue K; Truong MT; Sakai O
AJNR Am J Neuroradiol; 2017 Dec; 38(12):2334-2340. PubMed ID: 29025727
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
Ng SH; Liao CT; Lin CY; Chan SC; Lin YC; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Yang LY; Wang JJ
Eur Radiol; 2016 Nov; 26(11):4162-4172. PubMed ID: 26911889
[TBL] [Abstract][Full Text] [Related]
20. Characterization and therapy monitoring of head and neck carcinomas using diffusion-imaging-based intravoxel incoherent motion parameters-preliminary results.
Hauser T; Essig M; Jensen A; Gerigk L; Laun FB; Münter M; Simon D; Stieltjes B
Neuroradiology; 2013 May; 55(5):527-36. PubMed ID: 23417120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
